Results 141 to 150 of about 90,167 (303)

Efficacy and Safety Of Radiation Synovectomy with Yttrium-90 [PDF]

open access: yes, 1993
In this long term retrospective study of radiation synovectomy with Yttrium-90 (Y90), we evaluated the results of 164 applications in 82 patients with RA, OA with synovitis, ankylosing spondylitis and psoriatic arthritis.
Bozzone, P.   +4 more
core  

The Effect of Social Media Intervention as a Reminder and Educational Tool to Increase Treatment Adherence in Patients With Psoriasis: A Randomized Controlled Trial

open access: yesJEADV Clinical Practice, EarlyView.
In a 12‐week randomized trial of 159 psoriasis patients, educational messages and treatment reminders delivered through Facebook improved treatment adherence, reduced disease severity, and enhanced quality of life. Three times‐weekly messages provided the greatest benefits, including superior adherence, clearer skin, and higher patient satisfaction ...
Jennifer Lavina T. Ngo   +1 more
wiley   +1 more source

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives. [PDF]

open access: yes, 2019
Tofacitinib is an oral Janus kinase inhibitor approved for the treatment of psoriatic arthritis (PsA). It provides an alternative option for patients who have had an inadequate response and tolerance to other disease modifying antirheumatic drugs (DMARDs)
Beck, Kristen M   +4 more
core  

Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis [PDF]

open access: yes, 2009
OBJECTIVES:\ud To assess, quantify and summarise the cost of illness of rheumatoid arthritis (RA) and ankylosing spondylitis (AS) from the societal perspective.\ud \ud METHODS:\ud Original studies reporting costs of RA or AS were searched systematically.
Ament, A.J.H.A.   +4 more
core   +2 more sources

High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors [PDF]

open access: bronze, 2007
Carlos González‐Juanatey   +5 more
openalex   +1 more source

Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy

open access: yesPhytotherapy Research, EarlyView.
Natural compounds act on key cellular pathways in psoriasis by suppressing keratinocyte hyperproliferation, modulating Th17/IL‐17‐mediated immune responses, and reducing oxidative stress. These multi‐target effects highlight their potential as safer adjunctive therapies alongside conventional treatments.
Hye Jin Lee   +9 more
wiley   +1 more source

Epidemiology, genetics and management of psoriatic arthritis 2013: focus on developments of who develops the disease, its clinical features, and emerging treatment options

open access: yesPsoriasis: Targets and Therapy, 2013
Muhammad Haroon,1 Oliver FitzGerald,1 Robert Winchester2 1Department of Rheumatology, St Vincent's University Hospital, Dublin, Ireland; 2Division of Rheumatology, Columbia University College of Physicians and Surgeons, New York, NY, USA Abstract ...
Haroon M, FitzGerald O, Winchester R
doaj  

Home - About - Disclaimer - Privacy